Psychological and social factors influencing patients' treatment selection for localised prostate cancer

QR Code

Psychological and social factors influencing patients' treatment selection for localised prostate cancer

Chapter 3. Prostate cancer is the most common form of cancer in men in the United Kingdom (UK). A quarter of all new cases of cancer diagnosed in men are prostate cancers. In 2009, over 40,000 cases of prostate cancer were reported in the UK and more than 10,000 men die from the disease each year...

Full description

Bibliographic Details
Main Authors:	Robles, Luke A., Chou, Shihning, Cole, Owen J., Hamid, Akhlil, Griffiths, Amanda, Vedhara, Kavita
Other Authors:	Hamilton, Gerhard
Format:	Book Section
Published:	Intech 2013
Online Access:	https://eprints.nottingham.ac.uk/2841/

Similar Items

Dosimetric Study Of 3dcrt And Imrt Techniques Of Localised Prostate Cancer Using Male Pelvic Phantom
by: Raof, Nursyatina Abdul
Published: (2018)

Resistance training and reduction of treatment side effects in prostate cancer patients
by: Galvao, D., et al.
Published: (2006)

Hormone Ablation for the Treatment of Prostate Cancer: The Lived Experience
by: Ng, C., et al.
Published: (2006)

The supportive care needs for prostate cancer patients in Sarawak
by: Cheah, W.L, et al.
Published: (2016)

Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)

Endocrine and immune responses to resistance training in prostate cancer patients
by: Galvao, D, et al.
Published: (2008)

Radiation dose homogeneity and critical organs in radiotherapy treatment of prostate cancer
by: Khairi, Y., et al.
Published: (2021)

Soy, Isoflavone and Prostate Cancer
by: Jian, Le
Published: (2008)

Coffee Consumption and Prostate Cancer
by: Hoang, D., et al.
Published: (2014)

Soy, isoflavones, and prostate cancer
by: Jian, Le
Published: (2008)

Tea, coffee and prostate cancer
by: Lee, Andy, et al.
Published: (2009)

A study on survivin expression in prostate cancer and benign prostatic hyperplasia; and its association with pre-operative serum prostate specific antigen and gleason score in prostate cancer
by: Hadi, Normila Abdul
Published: (2016)

OA 06.08 Is Lung Cancer Screening Associated with a Negative Psychological Impact?
by: Clark, Marcia, et al.
Published: (2017)

Who makes the decision? Malaysian healthcare professionals' views on prostate cancer treatment
by: Lee, Yew Kong, et al.
Published: (2014)

Epitranscriptomic Determinants of Aggressive Prostate Cancer
by: Haigh, Daisy
Published: (2021)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

Lipid profiles of prostate cancer cells
by: Sorvina, A., et al.
Published: (2018)

Epidemiology and Prevention of Prostate Cancer in Vietnam
by: Dong, H., et al.
Published: (2014)

Lycopene and prostate cancer: emerging evidence
by: Fraser, Michelle, et al.
Published: (2005)

Psychological well-being focusing on anxiety and depression among patients with lower urinary tract symptoms in benign prostatic hyperplasia on pharmacological treatment in HUSM
by: Tanapalla, Sejjeetra Raynee
Published: (2020)

Phosphate-based glass microspheres for bone repair and localised chemotherapy and radiotherapy treatment of bone cancers
by: Milborne, Ben
Published: (2023)

Immunogold localisation of protochlorophyllide oxidoreductase in barley etioplasts
by: Shaw, P., et al.
Published: (1985)

OP36 Decisions about smoking in patients screened with the early cdt-lung test for the early detection of lung cancer: a qualitative study
by: Young, Ben, et al.
Published: (2017)

Study Of Terazosin In The Treatment Of Chronic Prostatitis
by: Phaik Yeong, Cheah
Published: (2002)

Doctors' approaches to decision support in counseling patients with localized prostate cancer: an Asian perspective
by: Cheong, Ai Theng, et al.
Published: (2016)

Prostatic diseases: is it toxic or genetic? Study of TNF alpha gene polymorphism and cigarette smoking in cases of prostate cancer and benign prostatic hyperplasia
by: M. Attalla, Sohayla, et al.
Published: (2016)

Epigenetic coregulators of androgen signalling in prostate cancer
by: Metzler, Veronika
Published: (2020)

Responding to a diagnosis of localized prostate cancer
by: Wall, David, et al.
Published: (2012)

Soybeans, Green Tea and Prostate Cancer Risk
by: Jian, Le, et al.
Published: (2008)

Tea and lycopene protect against prostate cancer
by: Jian, Le, et al.
Published: (2007)

Immunohistochemical expression of estrogen receptor alpha in benign prostatic hyperplasia and prostatic carcinoma in Iraqi patients
by: Mohammed, Wafaa R., et al.
Published: (2018)

Supporting patients in making treatment decisions for early prostate cancer: a qualitative study of healthcare professionals' views on barriers and challenges in an Asian country
by: Lee, Ping Yein, et al.
Published: (2016)

Nanotherapeutics as a localised drug delivery system for the treatment of GBM
by: Vasey, Catherine E
Published: (2021)

Regulation of vascular endothelial growth factor in prostate cancer
by: de Brot, Simone, et al.
Published: (2015)

Do preserved foods increase prostate cancer risk?
by: Jian, Le, et al.
Published: (2004)

Alcohol use and prostate cancer: a meta-analysis.
by: Fillmore, K, et al.
Published: (2009)

Protective Aspects of Tea and Prostate Cancer: Emerging Evidence
by: Lee, Andy, et al.
Published: (2013)

UPM Teaching Hospital' s milestone in prostate cancer therapy
by: The Health, .
Published: (2024)

Updates on molecular and biochemical development and progression of prostate cancer
by: Fahmy, Omar, et al.
Published: (2021)

To share or not to share: Malaysian healthcare professionals' views on localized prostate cancer treatment decision making roles
by: Lee, Yew Kong, et al.
Published: (2015)